PortViewPortView
BUDX logo

Cannabis Growth (BUDX) ETF Holdings & Analysis

ETFOther

$9.97-2.59%
1-year price historyRange $9.61 – $20.50
52-week range$9.97
$9.90$9.97

What BUDX does

Under typical market circumstances, this exchange-traded fund commits a minimum of 80% of its net assets (including any funds borrowed for investment) to publicly traded equities of businesses worldwide involved in the lawful cannabis sector ("Cannabis Companies"). The fund also has the option to allocate capital to shares of other exchange-traded funds (ETFs) that maintain a policy of investing at least 80% of their assets in Cannabis Companies, or to derivatives offering comparable economic exposure. This fund operates as a non-diversified portfolio.

Fund profile

Category
Other
AUM
$3.55M
52-week high
$9.97
52-week low
$9.90

Sector allocation

Basic Materials3.71%
Cash & Others26.40%
Consumer Cyclical4.02%
Consumer Defensive8.93%
Healthcare37.55%
Industrials2.61%
Real Estate12.65%
Technology4.13%

PortView Portfolio Insights

PortView analyzes how BUDX fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BUDX in PortView →

Related securities

Related stocks

Frequently asked questions

What does BUDX track?
BUDX is the Cannabis Growth ETF, a Other ETF.
What is the expense ratio of BUDX?
Expense ratio data for BUDX is shown on the page when available from our data provider.
What are the largest holdings in BUDX?
BUDX's top holdings are listed on this page when available.
How can PortView analyze BUDX overlap with other ETFs?
PortView computes the holdings overlap between BUDX and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.